Sort
85,873 grants matching “alzheimers”
TREAT AD Bioinformatics Core
$1,332,105Allan I Levey · Emory University · U54 · FY2025 · AG
Cell Biology and Functional Analysis
$1,332,008Fred H Gage · Translational Genomics Research Inst · U19 · FY2024 · AG
Central Noradrenergic Neuron Subtype Development and Function
$1,331,474Patricia Jensen · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
A resource for magnetic resonance and optical imaging
$1,331,290Ravinder Reddy · University Of Pennsylvania · P41 · FY2012 · EB
Role of PLD3 in nucleic acid recognition and brain function
$1,331,250David Nemazee · Scripps Research Institute, The · RF1 · FY2022 · AG
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging
$1,331,164Julie A Schneider · Rush University Medical Center · R01 · FY2021 · AG
'Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders'
$1,331,146Justin C McArthur · Johns Hopkins University · P01 · FY2018 · MH
Molecular Mechanisms of Synapse Development and Plasticity
$1,331,049Zheng Li · National Institute Of Mental Health · ZIA · FY2022 · MH
Dynamic Inverse Solutions for Multimodal Imaging
$1,330,840David A Boas · Massachusetts General Hospital · R01 · FY2008 · EB
GENE THERAPY FOR ALZHEIMERS DISEASE
$1,330,465Salk Institute For Biological Studies · P01 · FY2001 · AG
Indiana Alzheimer Disease Center
$1,330,156Bernardino Ghetti · Indiana Univ-Purdue Univ At Indianapolis · P30 · FY2007 · AG
Targeted Degradation of Extracellular Proteins to Enhance Brain Plasticity
$1,330,000Nicola J Allen · Salk Institute For Biological Studies · DP1 · FY2024 · NS
Targeted Degradation of Extracellular Proteins to Enhance Brain Plasticity
$1,330,000Nicola J Allen · Salk Institute For Biological Studies · DP1 · FY2025 · NS
CNS DEGENERATION CAUSED BY NOVEL PATHOGENS
$1,329,490University Of California San Francisco · P50 · FY2001 · NS
Alzheimer's Disease Research Center
$1,329,400Scott A Small · Columbia University Health Sciences · P30 · FY2025 · AG
Matched sets of full human gene-replacement mouse lines for MODEL-AD
$1,329,167Michael D Koob · University Of Minnesota · R56 · FY2021 · AG
PET Core
$1,328,537William J. Jagust · Northern California Institute/Res/Edu · U19 · FY2023 · AG
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
$1,327,969Roberta Diaz Brinton · University Of Arizona · R01 · FY2024 · AG
Anti-Viral therapy in Alzheimer's disease
$1,327,757Davangere P Devanand · Columbia University Health Sciences · R01 · FY2017 · AG
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
$1,327,713Jack H Freed · Cornell University · R24 · FY2023 · GM
TAUOPATHIES: GENOTYPE AND PHENOTYPE
$1,327,540University Of Pennsylvania · P01 · FY2003 · AG
Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)
$1,326,588Robert Willson Gillen · Ipaces, Llc · R44 · FY2023 · NS
Alzheimer's Disease Core Center
$1,326,393John Q. Trojanowski · University Of Pennsylvania · P30 · FY2007 · AG
Behavioral and Neural Plasticity in the Aged
$1,325,913University Of California Irvine · P01 · FY2003 · AG
Mechanisms of molecular machines that regulate the neuronal cytoskeleton
$1,325,057Antonina Roll-Mecak · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS